Increasing incidences of cancer patients requiring chemotherapy and prolonged IV antibiotic treatment is attributing to the rise in demand for PICCs
According to iData Research’s new market research report titled, European Vascular Access Device Market, the European Peripherally Inserted Central Catheter (PICC) Market is expected to grow to over $45 million by 2020. The growth is driven by the increasing conversion from devices such as Chronic Central Venous Catheters (CVC) and Peripheral Intravenous Catheters (PIVC). The PICC Market is comprised of the Conventional Peripherally Inserted Central Catheters and the Power-Injectable Peripherally Central Catheters markets.
The latest statistics from Cancer Research UK reports that there were 434,115 cases of cancer diagnosed within the 40 and older population in 2011. The increasing incidence of cancer patients requiring chemotherapy and prolonged IV antibiotic treatment will attribute to the rise in demand for PICCs.
One of the strongest segments driving the European PICC market is the Power-Injectable PICC’s. By 2020, power-injectable PICCs will increase as a percentage of total unit sales from 51% to over 70% in Europe. “Growth in this market is being driven by strong, double-digit growth in unit sales as the market transitions to power-injectable devices from conventional PICCs,” states Dr. Kamran Zamanian, CEO of iData Research. Benelux and Switzerland are expected to transition to using power-injectable devices faster than other regions in Europe, with the Benelux region expected to reach 100% conversion by 2020.
Peripherally Inserted Central Catheter Market by Segment, Europe, 2010 – 2020
New technological developments will focus on the reduction of infection rates and thrombosis, such as Antithrombogenic PICCs. C. R. Bard is set to launch an antimicrobial PICC family as well as a Thromboresistant PICC product.
Leading the market for European Peripherally Inserted Central Catheter (PICC) Market is C.R. Bard, which has separated its product lines into those used by interventional radiologists such as thePOWERPICC® catheter and POWERPICC® Solo® catheter; and for nurses which include the Q-Cath®and Poly Per-Q-Cath®.
Other major players driving market growth includes Medcomp, Vygon, Cook Medical, AngioDynamics, B. Braun and Teleflex.
20% Discount for September 2014
No comments:
Post a Comment